124 related articles for article (PubMed ID: 2573714)
1. Beta-adrenoceptor antagonist activities and binding affinities of timolol enantiomers in rat atria.
Karhuvaara S; Kaila T; Huupponen R
J Pharm Pharmacol; 1989 Sep; 41(9):649-50. PubMed ID: 2573714
[TBL] [Abstract][Full Text] [Related]
2. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
3. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
4. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
Juberg EN; Minneman KP; Abel PW
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
Sillence MN; Moore NG; Pegg GG; Lindsay DB
Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
[TBL] [Abstract][Full Text] [Related]
6. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
Williamson KL; Broadley KJ
Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
[TBL] [Abstract][Full Text] [Related]
7. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
8. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
Hoey A; Jackson C; Pegg G; Sillence M
Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
[TBL] [Abstract][Full Text] [Related]
9. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
Nathanson JA
Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart.
Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE
J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571
[TBL] [Abstract][Full Text] [Related]
11. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterisation of beta-adrenoceptors on intact equine peripheral blood lymphocytes with the radioligand (-)-[125I]-iodocyanopindolol.
Abraham G; Broddet OE; Ungemach FR
Equine Vet J; 2001 Sep; 33(5):487-93. PubMed ID: 11558744
[TBL] [Abstract][Full Text] [Related]
14. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenoceptors of the human myocardium: determination of beta 1 and beta 2 subtypes by radioligand binding.
Heitz A; Schwartz J; Velly J
Br J Pharmacol; 1983 Dec; 80(4):711-7. PubMed ID: 6100846
[TBL] [Abstract][Full Text] [Related]
16. Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies.
Bundkirchen A; Brixius K; Bölck B; Nguyen Q; Schwinger RH
Eur J Pharmacol; 2003 Jan; 460(1):19-26. PubMed ID: 12535855
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocking potency and selectivity of bopindolol and its two metabolites for beta 1- and beta 2-adrenergic receptors as assessed by radioligand binding assay.
Sakuma N; Tsuchihashi H; Hosohata Y; Akashi H; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 May; 14(5):250-5. PubMed ID: 1685186
[TBL] [Abstract][Full Text] [Related]
18. Identification of beta 2-adrenoceptors on guinea pig alveolar macrophages using (-)-3-[125I]iodocyanopindolol.
Leurs R; Beusenberg FD; Bast A; Van Amsterdam JG; Timmerman H
Inflammation; 1990 Aug; 14(4):421-6. PubMed ID: 1974244
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure control.
Himber J; Velly J; Kintz P; de Burlet G; Andermann G; Leclerc G
Methods Find Exp Clin Pharmacol; 1989 May; 11(5):315-21. PubMed ID: 2547127
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of bunitrolol for beta 1- and beta 2-adrenergic receptors and 5HT1B-receptors: assessment by biphasic Scatchard plots and biphasic displacement curve analysis with 125I-iodocyanopindolol and 3H-CGP12177.
Tsuchihashi H; Nagotomo T; Imai S
Jpn J Pharmacol; 1989 Jun; 50(2):93-100. PubMed ID: 2570175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
